Which is better for treating influenza B, Arbidol or Oseltamivir?
Influenza B refers to type B influenza. Arbidol is a broad-spectrum antiviral medication available in various formulations including tablets and capsules. Oseltamivir, on the other hand, is a neuraminidase inhibitor available in multiple formulations such as granules and capsules. Generally speaking, the choice between arbidol and oseltamivir for treating type B influenza depends on the patient's age. Arbidol is suitable for adults aged 18 to 65 years, while oseltamivir is suitable for both adults and children aged 1 year and older. It is recommended to choose the medication under a doctor's guidance. A detailed explanation is as follows:

Arbidol primarily works by blocking the fusion of the viral lipid membrane with the host cell membrane, thereby effectively inhibiting the virus from entering the cell for replication. This mechanism interrupts the viral transmission chain at its source, reducing viral replication within the body, ultimately achieving therapeutic effects against type B influenza. It is generally suitable for adults aged 18 to 65 years.
Oseltamivir is primarily used to treat influenza caused by influenza A and B viruses. If a patient is diagnosed with type B influenza and begins treatment within 48 hours of symptom onset, oseltamivir can effectively alleviate symptoms and shorten the duration of illness. Oseltamivir has a broad age range of applicability and is suitable for treating both adults and children aged 1 year and older with influenza A or B.
During flu season, it is recommended to take preventive measures such as receiving a flu vaccine and maintaining good personal hygiene habits to reduce the risk of infection.